Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Rossella Martinello"'
Autor:
Danilo Galizia, Andrea Milani, Elena Geuna, Rossella Martinello, Celeste Cagnazzo, Manuela Foresto, Virginia Longo, Paola Berchialla, Gianfranca Solinas, Adele Calori, Bruna Grasso, Chiara Volpone, Gisella Bertola, Gisella Parola, Giancarla Tealdi, Piero Luigi Giuliano, Anna Maria Ballari, Massimo Aglietta, Filippo Montemurro
Publikováno v:
Cancer Medicine, Vol 7, Iss 9, Pp 4339-4344 (2018)
Abstract Background We recently reported that self‐evaluation of the incidence and severity of treatment‐related side effects (TSEs) using a National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) v4.0‐based quest
Externí odkaz:
https://doaj.org/article/484b3bee40944291884d030fd257ac71
Autor:
Gisella Parola, Chiara Volpone, Anna M aria Ballari, Paola Berchialla, Celeste Cagnazzo, Gianfranca Solinas, Virginia Longo, Gisella Bertola, Massimo Aglietta, Manuela Foresto, Bruna Grasso, Elena Geuna, Andrea Milani, Rossella Martinello, Piero Luigi Giuliano, Danilo Galizia, Filippo Montemurro, Adele Calori, Giancarla Tealdi
Publikováno v:
Cancer Medicine, Vol 7, Iss 9, Pp 4339-4344 (2018)
Background We recently reported that self‐evaluation of the incidence and severity of treatment‐related side effects (TSEs) using a National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) v4.0‐based questionnaire
Autor:
Rossella Martinello, Celeste Cagnazzo, G Tealdi, Manuela Foresto, Chiara Volpone, Virginia Longo, Gianfranca Solinas, A.M. Ballari, Paola Berchialla, S Gallizioli, Gisella Parola, Filippo Montemurro, Danilo Galizia, Adele Calori
Publikováno v:
Cancer Research. 77:P5-11
Background: Collection and analysis of chemotherapy-related side-effects (CSE) is critical in the management of cancer patients (pts) both in experimental trials and in the clinical practice. Usually, most of the available conventional systems like t
Autor:
G Zucchini, Di Virgilio, Annalisa Petrelli, L Martincich, A. Nuzzo, Marilisa Cargnelutti, Rossella Martinello, Riccardo Ponzone, Anna Sapino, Ivana Sarotto, Silvia Giordano, Franziska Kubatzki, Filippo Montemurro
Publikováno v:
Cancer Research. 77:P1-09
Background: Micro RNAs (miRNAs) are short, non-coding RNA molecules that act as negative regulators of gene-expression, mainly at the post-transcriptional level. Alterations in miRNA functions have been implicated in a variety of human diseases, incl
Autor:
Laura Pizzuti, Lucia Del Mastro, Alessia D'Alonzo, Andrea Milani, Ornella Garrone, Rossella Martinello, Paolo Becco, Mario Airoldi, Carla Barone, Patrizia Vici, Alessandro Bonzano, Elisa Bellini, Filippo Montemurro
Background Significant and symptomatic cardiac comorbidity is a contraindication to adjuvant trastuzumab in breast cancer patients. However, some patients with asymptomatic, nonlimiting cardiac comorbidity and normal baseline left ventricular ejectio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59f230b89ae803955c6169c6f659af6c
http://hdl.handle.net/11567/947575
http://hdl.handle.net/11567/947575
Autor:
Susana García-Recio, Vincenzo Adamo, Patricia Galván, Octavio Burgués Gasión, Eduardo Martínez de Dueñas, Rosalia Caballero, Laia Paré, Federico Rojo, Maria Vidal, Ramon Perez, Aleix Prat, Charles M. Perou, Ana Lluch, Eva Carrasco, Roger R. Gomis, Rossella Martinello, Javier Cortes, Juan Miguel Cejalvo, Paolo Nuciforo, Angel Guerrero-Zotano, Barbara Adamo, Silvia Antolín, Vicente Peg, I. Blancas, Montserrat Muñoz, Joan Albanell, Jose Ignacio Chacon Lopez-Muniz
Publikováno v:
Cancer Research
r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
instname
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
CANCER RESEARCH
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
instname
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
CANCER RESEARCH
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Biological changes that occur during metastatic progression of breast cancer are still incompletely characterized. In this study, we compared intrinsic molecular subtypes and gene expression in 123 paired primary and metastatic tissues from breast ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d585344d4f88d1666f4549688175c2d
https://europepmc.org/articles/pmc5822682?pdf=render
https://europepmc.org/articles/pmc5822682?pdf=render
Publikováno v:
Expert Opinion on Pharmacotherapy. 15:1191-1195
The San Antonio Breast Cancer Symposium is considered by researchers and physicians involved in breast cancer management as one of the most important international events on the subject. A dense program of plenary presentations of novel findings, mai
Autor:
Rossella Martinello, Giuseppe Viale, Franco Nolè, Stefania Redana, Massimo Aglietta, Filippo Montemurro, Laura Adamoli, Valentina Rossi, Gaetano Aurilio, Elena Verri, Anna Sapino
Publikováno v:
The Breast. 23:44-49
Background Five to 10% of women with newly diagnosed breast cancer have synchronous metastases ( de novo stage IV). A further 20% will develop metastases during follow-up (recurring stage IV). We compared the clinical outcomes of women with HER2-posi
Autor:
Giorgia Zucchini, Caterina Aversa, Annamaria Nuzzo, Rossella Martinello, Elena Geuna, Andrea Milani, Filippo Montemurro
Publikováno v:
Expert opinion on investigational drugs. 25(4)
ErbB2 overexpression and/or gene amplification is present in 20% of all breast cancers and characterizes an aggressive form of this disease. Despite the availability of several active drugs that have yielded substantial survival improvements, most pa
Autor:
Andrea, Milani, Elena, Geuna, Giorgia, Zucchini, Caterina, Aversa, Rossella, Martinello, Filippo, Montemurro
Publikováno v:
Minerva ginecologica. 68(5)
About 10% of breast cancers are associated with the inheritance of autosomal dominant breast cancer susceptibility alleles BRCA1 and BRCA2. Until recently, the medical management of BRCA mutation-associated breast cancer has not differed from that of